Amphadase
Active Ingredient(s): HyaluronidaseFirst Approved by the FDA: October 26, 2004
Pharmaceutical Company: AMPHASTAR PHARM
Welcome to the Amphadase information hub.Scroll down to read supplemental details and discuss this drug.
Amphadase Overview
The hyaluronidases (EC 3.2.1.35) are a family of enzymes that degrade hyaluronic acid. In humans, there are six associated genes, including HYAL1, HYAL2, HYAL3, and PH-20/SPAM1.[1] Contents 1 Use as a drug 2 Role in cancer 3 Role in pathogenesis 4 Role in fertilization 5 References 6 External links Use as a drug Hyaluronidase Systematic (IUPAC) name hyaluronidase Clinical data AHFS/Drugs.com Consumer Drug Information Pregnancy cat. C Legal status ? Routes subcutane ... Read more Amphadase DetailsDetails May Include Instructions, Side Effects, Interactions, Etc.
Drug monograph is from Wikipedia. All text is available under the terms of the GFDL
(GNU Free Documentation License) | http://en.wikipedia.org/wiki/Hyaluronidase
Recent Amphadase Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Hyaluronidase
- Injection: 1,500 units/vial, 150 units/ml, 150 units/vial, 150unit/ml, 150USPunits/ml, 200 units/vial, 200units/ml, 6,200 units/vial
- Powder for Reconstitution: 6200IU/5ml
Other drugs which contain Hyaluronidase or a similar ingredient: (5 results)
- Hyaluronidase
- Hydase Hyaluronidase
- Hylenex Recombinant Hyaluronidase Recombinant Human
- Vitrase Hyaluronidase
- Wydase Hyaluronidase
